MedTrace Logo

Prevalence of Hypogonadism in Male Cancer Patients

NCT00472940 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 135

Last updated 2020-11-27

No results posted yet for this study

Summary

Cancer and its complications are common problems. In most cases, this condition has a profound impact on survival and quality of life (QoL). Fatigue, sexual dysfunction, decreased sexual drive, depression and poor appetite are commonly seen in these patients. However, these symptoms also are seen in men with other conditions including those with low testosterone levels.

The objective of this study is to determine the number of male patients with cancer that have low testosterone levels and to establish the relationship between testosterone levels and the symptoms that these patients experience.

Conditions

Sponsors & Collaborators

  • Michael E. DeBakey VA Medical Center

    collaborator FED

  • Solvay Pharmaceuticals

    collaborator INDUSTRY

  • Baylor College of Medicine

    lead OTHER

Principal Investigators

  • Jose M Garcia, MD · Baylor College of Medicine, Michael E. DeBakey VAMC

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2020-09-02
Completion
2020-09-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00472940 on ClinicalTrials.gov